drugset / Trial / NCT05797623

Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

NCT05797623 ↗

Phase 2 Unknown 78 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a multicenter, randomized, double-blind, and open-label, placebo-controlled phase II clinical study. In order to evaluate the effectiveness and safety of trappa ethanolamine tablets combined with ciclosporin in the treatment of patients with non-severe aplastic anemia.

Timeline

Start
2023-04-26
Primary completion
2024-05-30
Completion
2025-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Trappa ethanolamine Unknown — —
Background Cyclosporine Peptide — —

Indications